Manufacturer
Eugia US LLC
73 drugs, 93 product strengths, 17 recalls on record.
Drugs Eugia US LLC makes
Furosemide-4.2%Generic · 52 makersPharmacies pay from$0.75Unavailable3 open recallsPantoprazole+2.7%Generic · 62 makersPharmacies pay from$1.103 open recallsEsomeprazole-3.4%Generic · 107 makersPharmacies pay from$3.844 open recallsSildenafil+2.3%Generic · 54 makersPharmacies pay from$1.572 open recallsNaloxone-1.6%Generic · 42 makersPharmacies pay from$12.541 open recallAzithromycin+0.9%Generic · 45 makersPharmacies pay from$1.63Being discontinuedLevetiracetam-1.9%Generic · 63 makersPharmacies pay from$1.702 open recallsHydralazine-1.0%Generic · 37 makersPharmacies pay from$0.78In shortage3 open recallsOlanzapine+1.3%Generic · 35 makersPharmacies pay from$2.432 open recallsSumatriptan+3.4%Generic · 39 makersPharmacies pay from$7.60Methocarbamol-2.1%Generic · 57 makersPharmacies pay from$1.162 open recallsTriamcinolone-0.9%Generic · 70 makersPharmacies pay from$0.67In shortage15 open recallsDexamethasone+3.2%Generic · 59 makersPharmacies pay from$1.19Unavailable10 open recallsMethylprednisolone-4.0%Generic · 25 makersPharmacies pay from$3.03Unavailable5 open recallsMedroxyprogesterone+0.2%Generic · 23 makersPharmacies pay from$3.45Being discontinued5 open recallsTestosterone-3.4%Generic · 29 makersPharmacies pay from$35.2068 open recallsProgesterone+1.7%Generic · 25 makersPharmacies pay from$6.99Being discontinued4 open recallsLidocaine-1.8%Generic · 396 makersPharmacies pay from$1.74Unavailable59 open recallsAcetaminophen+1.6%Generic · 255 makersPharmacies pay from$0.6619 open recallsPhenylephrine-2.3%Generic · 81 makersPharmacies pay from$1.4517 open recallsTobramycin-1.1%Generic · 42 makersPharmacies pay from$5.48Being discontinued6 open recallsProchlorperazine-1.9%Generic · 41 makersPharmacies pay from$3.351 open recallTranexamic acid-1.6%Generic · 39 makersPharmacies pay from$24.882 open recallsCaffeine-0.1%Generic · 37 makersPharmacies pay from$2.49Fluphenazine+59.4%Generic · 30 makersPharmacies pay from$7.0910 open recallsVoriconazole+8.8%Generic · 30 makersPharmacies pay from$25.005 open recallsPosaconazole+1.7%Generic · 28 makersPharmacies pay from$62.01Being discontinued1 open recallRocuroniumGeneric · 27 makersNo weekly priceUnavailable1 open recallDaptomycin+7.4%Generic · 25 makersPharmacies pay from$25.56Being discontinued2 open recallsGentamicin+14.9%Generic · 23 makersPharmacies pay from$2.525 open recallsLinezolid+2.3%Generic · 23 makersPharmacies pay from$44.22SuccinylcholineGeneric · 23 makersNo weekly priceBeing discontinued4 open recallsEphedrineGeneric · 22 makersNo weekly price1 open recallNicardipine+2.6%Generic · 21 makersPharmacies pay from$34.466 open recallsBortezomibGeneric · 21 makersNo weekly price1 open recallCarboprostGeneric · 21 makersNo weekly priceThiamine-5.4%Generic · 20 makersPharmacies pay from$1066 open recallsZoledronic acid-2.0%Generic · 20 makersPharmacies pay from$46.571 open recallAzacitidineGeneric · 20 makersNo weekly priceUnavailable1 open recallFluorouracil+5.2%Generic · 18 makersPharmacies pay from$25.89FulvestrantGeneric · 20 makersNo weekly priceBeing discontinuedDecitabineGeneric · 18 makersNo weekly priceBeing discontinued1 open recallFosaprepitantGeneric · 17 makersNo weekly priceBeing discontinuedErtapenem-6.5%Generic · 16 makersPharmacies pay from$2491 open recallAcetylcysteine+4.2%Generic · 13 makersPharmacies pay from$96.564 open recallsAmpicillin-0.3%Generic · 13 makersPharmacies pay from$13.20Being discontinued1 open recallPiperacillin / tazobactamNo changeGeneric · 13 makersPharmacies pay from$34.93Being discontinuedBivalirudinGeneric · 13 makersNo weekly priceMeropenem+7.6%Generic · 12 makersPharmacies pay from$50.431 open recallArgatrobanGeneric · 12 makersNo weekly price2 open recallsPalonosetronGeneric · 12 makersNo weekly priceBeing discontinuedPlerixaforGeneric · 12 makersNo weekly priceBeing discontinuedLeuprolideNo changeGeneric · 10 makersPharmacies pay from$198Being discontinuedKetamine+1.4%Generic · 9 makersPharmacies pay from$55.638 open recallsAmpicillin / sulbactamGeneric · 10 makersNo weekly priceArsenic trioxideGeneric · 10 makersNo weekly priceBeing discontinuedCarboplatinGeneric · 10 makersNo weekly priceUnavailableIbandronate+3.4%Generic · 9 makersPharmacies pay from$82.97Vasopressin (USP)Generic · 10 makersNo weekly priceVecuroniumGeneric · 10 makersNo weekly price2 open recallsClofarabineGeneric · 9 makersNo weekly priceBusulfanGeneric · 7 makersNo weekly price1 open recallIcatibantGeneric · 7 makersNo weekly priceBeing discontinuedMesnaGeneric · 7 makersNo weekly pricePolymyxin BGeneric · 7 makersNo weekly price5 open recallsFondaparinux-5.2%Generic · 5 makersPharmacies pay from$111NafcillinGeneric · 6 makersNo weekly price4 open recallsAmphotericin BGeneric · 5 makersNo weekly price1 open recallTigecyclineGeneric · 5 makersNo weekly priceDactinomycinGeneric · 4 makersNo weekly priceOxacillinGeneric · 4 makersNo weekly price3 open recallsDexrazoxaneGeneric · 2 makersNo weekly price17-alpha-hydroxyprogesteroneGeneric · 1 makerNo weekly price
Recalls
Class IIIOngoingJun 10, 2026Lidocaine HCl InjectionLabeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scanEugia US LLC · D-0552-2026Class IIOngoingJun 25, 2025Gentamicin InjectionFailed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.Eugia US LLC · D-0472-2025Class IIOngoingMay 7, 2025Tirofiban Hydrochloride Injection 12.5 mg/250 mLOut-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.Eugia US LLC · D-0390-2025Class IIOngoingMay 7, 2025Tirofiban Hydrochloride Injection 5 mg/100 mLOut-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.Eugia US LLC · D-0389-2025Class IIOngoingApr 23, 2025Testosterone Cypionate InjectioncGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.Eugia US LLC · D-0363-2025Class IIOngoingJan 15, 2025medroxyPROGESTERone Acetate Injectable SuspensionCGMP DeviationsEugia US LLC · D-0185-2025Class IIOngoingJan 15, 2025Progesterone Injection USPPresence of Particulate Matter: A market complaint was received of a glass piece in the vial.Eugia US LLC · D-0186-2025Class IIOngoingAug 7, 2024Progesterone InjectionPresence of Particulate Matter: Complaint received of a glass particle in the vial.Eugia US LLC · D-0624-2024Class IIOngoingJun 26, 2024Dexamethasone Sodium Phosphate injection USPFailed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.Eugia US LLC · D-0555-2024Class IIIOngoingJun 26, 2024Eptifibatide injection 20mg/10mLFailed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.Eugia US LLC · D-0556-2024Class IOngoingApr 17, 2024Methocarbamol InjectionPresence of Particulate MatterEugia US LLC · D-0440-2024Class IIOngoingMar 27, 2024Nicardipine Hydrochloride InjectionFailed Impurities/Degradation Specifications: Out of specification for organic impuritiesEugia US LLC · D-0391-2024Class IIOngoingMar 27, 2024Nicardipine Hydrochloride InjectionFailed Impurities/Degradation Specifications: Out of specification for organic impuritiesEugia US LLC · D-0390-2024Class IITerminatedMar 20, 2024Tobramycin for InjectionFailed Stability Specification: Water determination was found not complying with specification.Eugia US LLC · D-0385-2024Class IIOngoingMar 13, 2024Methylprednisolone acetate Injectable SuspensionFailed Dissolution SpecificationsEugia US LLC · D-0366-2024Class IIOngoingOct 11, 2023Triamcinolone Acetonide Injectable SuspensionPresence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.Eugia US LLC · D-0041-2024Class IIOngoingJan 11, 2023Acyclovir Sodium Injection 1Presence of Particulate Matter: Customer complaint of dark particles found inside the vialEugia US LLC · D-0095-2023
About Eugia US LLC
No comments yet. Questions, tips, what worked for you - start the conversation.